terlipressin has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Golestaneh, L; Neugarten, J | 1 |
Kim, JW | 1 |
Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY | 1 |
1 review(s) available for terlipressin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Dual Organ Duel: The Hepatorenal Axis.
Topics: Acute Kidney Injury; Animals; Antihypertensive Agents; Antiviral Agents; Cytochrome P-450 Enzyme System; Hepatitis C; Hepatorenal Syndrome; Humans; Liver Diseases; Lypressin; Renal Insufficiency, Chronic; Terlipressin | 2017 |
1 trial(s) available for terlipressin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Topics: Aged; Cardiac Output; Drug Therapy, Combination; Female; Hemodynamics; Hepatitis B; Hepatitis C; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Venous Pressure | 2002 |
1 other study(ies) available for terlipressin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
[Type 2 hepatorenal syndrome in a cirrhotic patient who underwent gastric cancer surgery].
Topics: Adult; Hepatitis C; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Portasystemic Shunt, Transjugular Intrahepatic; Stomach Neoplasms; Terlipressin; Tomography, X-Ray Computed; Vasoconstrictor Agents | 2010 |